The topology of DNA has a profound influence on how its genetic information is regenerated, rearranged, and expressed in vivo. Consequently, the enzymes that regulate the topological structure of nucleic acids play a crucial role in controlling the cellular function of DNA. One class of enzymes, the type II topoisomerases, catalyze changes in the topological state of DNA by passing one intact DNA helix through a transient double- stranded break made in a second helix. These ubiquitous enzymes exist in vivo as phosphoproteins, are essential for the viability of eukaryotic cells, and are involved in many aspects of DNA replication, transcription, repair, chromosome structure, nuclear structure, and chromosome segregation. In addition, topoisomerase II appears to be the primary cellular target for several major classes of antineoplastic agents. Despite the importance of topoisomerase II to the eukaryotic cell and to the clinical treatment of human cancers, very little of its enzymatic mechanism or physiological regulation is understood. Therefore, the ultimate goal of this proposal is to define the function and biology of the enzyme in eukaryotic cells. More specifically, the aims of this proposal are 1) to describe the mechanism of the topoisomerase II-catalyzed double-stranded DNA passage reaction, 2) to determine the role of serine phosphorylation as a physiological regulator of the enzyme, and 3) to determine the mechanism by which anti-neoplastic agents alter the activity of topoisomerase II. Drosophila Kc tissue culture cells, an established embryonic line, will be employed as a research model. In order to more fully characterize the double-stranded DNA passage reaction of topoisomerase II, a kinetic approach will be coupled with enzyme- substrate binding studies, chemical modification experiments, and a conformational analysis of the structural transitions undergone by the enzyme during the course of DNA strand passage. The role of serine phosphorylation as a physiological regulator of the enzyme will be assessed by examining the kinetic properties of modified topoisomerase II, defining in vivo and in vitro sites of phosphorylation, identifying the enzymes responsible for the in vivo phosphorylation/dephosphorylation of topoisomerase II, and by correlating levels of modification with the cellular activity and location of the enzyme. Topoisomerase II-antineoplastic drug interactions will be studied by kinetic and binding experiments, by generating mutant cell lines with drug-resistant enzymes, and by defining relationships between enzyme concentration in vivo and drug-induced cytotoxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM033944-05
Application #
3284167
Study Section
Biochemistry Study Section (BIO)
Project Start
1984-07-01
Project End
1992-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Oviatt, Alexandria A; Kuriappan, Jissy A; Minniti, Elirosa et al. (2018) Polyamine-containing etoposide derivatives as poisons of human type II topoisomerases: Differential effects on topoisomerase II? and II?. Bioorg Med Chem Lett 28:2961-2968
Dahlman, Kimberly Brown; Weinger, Matthew B; Lomis, Kimberly D et al. (2018) Integrating Foundational Sciences in a Clinical Context in the Post-Clerkship Curriculum. Med Sci Educ 28:145-154
Niederhoffer, Eric C; Cline, Susan D; Osheroff, Neil et al. (2017) Teaching Biochemistry and Genetics to Students of Dentistry, Medicine, and Pharmacy 6th International Conference of the Association of Biochemistry Educators (ABE) Clearwater Beach, FL, USA, May 7-11, 2017. Med Sci Educ 27:855-859
Ashley, Rachel E; Dittmore, Andrew; McPherson, Sylvia A et al. (2017) Activities of gyrase and topoisomerase IV on positively supercoiled DNA. Nucleic Acids Res 45:9611-9624
Ashley, Rachel E; Lindsey Jr, R Hunter; McPherson, Sylvia A et al. (2017) Interactions between Quinolones and Bacillus anthracis Gyrase and the Basis of Drug Resistance. Biochemistry 56:4191-4200
Minniti, Elirosa; Byl, Jo Ann W; Riccardi, Laura et al. (2017) Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase II?. Bioorg Med Chem Lett 27:4687-4693
Infante Lara, Lorena; Sledge, Alexis; Laradji, Amine et al. (2017) Novel trifluoromethylated 9-amino-3,4-dihydroacridin-1(2H)-ones act as covalent poisons of human topoisomerase II?. Bioorg Med Chem Lett 27:586-589
Kristoffersen, Emil L; Givskov, Asger; Jørgensen, Line A et al. (2017) Interlinked DNA nano-circles for measuring topoisomerase II activity at the level of single decatenation events. Nucleic Acids Res 45:7855-7869
Yu, Xiang; Davenport, James W; Urtishak, Karen A et al. (2017) Genome-wide TOP2A DNA cleavage is biased toward translocated and highly transcribed loci. Genome Res 27:1238-1249
Ashley, Rachel E; Blower, Tim R; Berger, James M et al. (2017) Recognition of DNA Supercoil Geometry by Mycobacterium tuberculosis Gyrase. Biochemistry 56:5440-5448

Showing the most recent 10 out of 179 publications